314
Views
29
CrossRef citations to date
0
Altmetric
Reviews

Ceramic nanocarriers: versatile nanosystem for protein and peptide delivery

, , &
Pages 241-259 | Published online: 25 Dec 2012

Bibliography

  • Nayak AK. Advances in therapeutic protein production and delivery Int J Pharm Pharm Sci 2010;2(2):1-5
  • Vyas SP, Rawat M, Rawat A. Pegylated protein encapsulated multivesicular liposomes: a novel approach for sustained release of interferon alpha. Drug Dev Ind Pharm 2006;32:699-707
  • Rawat M, Singh D, Saraf S, Saraf S. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme. Drug Dev Ind Pharm 2008;34:181-8
  • Shahnaz G, Iqbal J, Rahmat D, Development and in vivo characterization of a novel peptide drug delivery system providing extended plasma half life. J Control Release 2012;157:375-82
  • San Jose. A New Report by Global Industry Analysts, Inc. 2008. Available from: http://www.perweb.com/release/protein [Last accessed 16 march 2012]
  • Torchilin VP, Lukyanov AN. Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discov Today 2003;8(6):259-66
  • Rawat M, Singh D, Saraf S, Saraf S. Nanocarriers: promising vehicle for bioactive drugs. Biol Pharm Bull 2006;29(9):1790-8
  • Tan ML, Choong PFM, Dass CR. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides 2010;31:184-93
  • Strebhardt K, Ullrich A. Paul Ehrlich's magic bullet concept: 100 years of progress. Nat Rev Cancer 2008;8:473-80
  • Fathi M, Mozafari MR, Mohebbi M. Nanoencapsulation of food ingredients using lipid based delivery systems. Trends Food Sci Technol 2012;23:13-27
  • Italia JL, Bhatt DK, Bhardwaj V, PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to sandimmune neoral®. J Control Release 2007;119(2):197-206
  • Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 2007;59:478-90
  • Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 2012;8:147-66
  • Lei Y, Sheldon BW, Webster TJ. Nanophase ceramics for improved drug delivery: current opportunities and challenges. Am Ceram Soc Bull 2010;89(2):24-33
  • Vyas SP, Dixit VK. Pharmaceutical biotechnology. CBS Publishers and Distributors; New Delhi, India; 2008
  • Li YP, Pei YY, Zhang XY, PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release 2001;71:203-11
  • Mahato RI, Narang AS, Thoma L, Miller DD. Emerging trends in oral delivery of peptide and protein drugs. Crit Rev Ther Drug Del 2003;20:153-214
  • Roberts MJ, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 2002;54:459-76
  • Brocchini S, Godwin A, Balan S, Disulfide bridge based PEGylation of proteins. Adv Drug Deliv Rev 2008;60:4-13
  • Bohne A, Von Der Lieth CW. Glycosylation of proteins: a computer based method for the rapid exploration of comformational space of n-glycans. Pac Symp Biocomput 2002;7:285-96
  • Sola RJ, Griebenow K. Effects of glycosylation on the stability of protein pharmaceuticals. J Pharm Sci 2009;98:1223-45
  • Sola RJ, Griebenow K. Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs 2010;24:9-21
  • Shi Q, Domurado M, Domurado D. Effect of protein chemical hydrophobization on antiglucose oxidase immunoglobulin production in mouse. Pharmacol Toxicol 1995;76(4):278-85
  • Banga AK. Therapeutics peptides and proteins: formulation, processing and delivery system. CRC Press: Taylor and Francis group, Boca Raton, FL; 2006
  • Brown LR. Commercial challenges of protein delivery. Expert Opin Drug Deliv 2005;2(1):29-42
  • Katsuhide Y, Ogasahara K, Sugino Y, Matsushiro A. Effect of a single amino acid substitution on stability of conformation of a protein. Nature 1977;267:274-5
  • Kan KS, Coleman R. The calcium ionophore A23187 increases the tight-junctional permeability in rat liver. Biochem J 1988;256:1039-41
  • Pillai O, Panchagnula R. Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers. J Control Release 2003;89(1):127-40
  • Emerich DF, Thanos CG. Nanotechnology and medicine. Expert Opin Biol Ther 2003;3:655-63
  • Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today 2003;8:1112-20
  • Rawat M, Saraf S, Saraf S. Influence of selected formulation variables on the preparation of enzyme-entrapped eudragit S100 microspheres. AAPS PharmSciTech 2007;8:289-97
  • Rawat M, Saraf S. Formulation optimization of double emulsification method for preparation of enzyme-loaded Eudragit S100 microspheres. J Microencapsul 2009;26(4):306-14
  • Wang T, Hu Y, Leach MK, Erythropoietin-loaded oligochitosan nanoparticles for treatment of periventricular leukomalacia. Int J Pharm 2012;422(1–2):462-71
  • Ramachandran R, Paul W, Sharma CP. Synthesis and characterization of PEGylated calcium phosphate nanoparticles for oral insulin delivery. J Biomed Mater Res B Appl Biomater 2009;88:41-8
  • Subramani K, Pathak S, Hosseinkhani H. Recent trends in diabetes treatment using nanotechnology. Dig J Nanomat Biostructures 2012;7(1):85-95
  • Holzapfel BM, Reichert JC, Schantz JT, How smart do biomaterials need to be? A translational science and clinical point of view. Adv Drug Deliv Rev 2012;64(10):1-23
  • Luo D, Han E, Belcheva N, Saltzman WM. A self-assembled, modular DNA delivery system mediated by silica nanoparticles. J Control Release 2004;95:333-41
  • Sekhon BS, Kamboj SR. Inorganic nanomedicine – Part 1. Nanomedicine 2010;6:516-22
  • Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005;26:5474-91
  • Louis-Ugbo J, Kim HS, Boden SD, Retention of I-125-labeled recombinant human bone morphogenetic protein-2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis model. J Orthop Res 2002;20(5):1050-9
  • Ruhe PQ, Boerman OC, Russel FGM, In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med 2006;17(10):919-27
  • Xu HHK, Weir MD, Simon CG. Injectable and strong nanoapatite scaffolds for cell/growth factor delivery and bone regeneration. Dent Mater 2008;24:1212-22
  • Raghvendra SR. Nano-clays and drug delivery system: an overview. Int J Pharm World Rev 2012;3(3):1-16
  • Ambati J, Lopez AM, Cochran D, Engineered silica nanocarriers as a high-payload delivery vehicle for antioxidant enzymes. Acta Biomater 2012;8(6):2096-103
  • Murat A, Neşe BS, Meryem O, Adsorption of bovine serum albumin (BSA) on clinoptilolite. Biol Chem 2008;36(1):21-9
  • Kamble R, Ghag M, Gaikawad S, Panda BK. Halloysite nanotubes and applications: a review. J Adv Sci Res 2012;3(2):25-9
  • Vasilev K, Zihan P, Krishna K, Tailoring the surface functionalities of titania nanotube arrays. Biomaterials 2010;31:532-40
  • Cho SJ, Kim HJ, Lee JH, Silica coated titania nanotubes for drug delivery system. Mater Lett 2010;64:1664-7
  • Riman RE, Suchanek WL, Lencka MM. Hydrothermal crystallization of ceramics. Ann Chim-Sci Mat 2002;27(6):15-36
  • Zawadzki M, Wrzyszcz J. Hydrothermal synthesis of nanoporous zinc aluminate with high surface area. Mater Res Bull 2000;35:109-14
  • Choi SJ, Oh JM, Choy JH. Biocompatible ceramic nanocarrier for drug delivery with high efficiency. J Ceram Soc Jpn 2009;117:543-9
  • Takatori K, Tani T, Watanabe N, Kamiya N. Preparation and characterization of nano-structured ceramic powders synthesized by emulsion combustion method. J Nanopart Res 1999;1:197-204
  • Segal D. Chemical synthesis of ceramic materials. J Mater Chem 1997;7(8):1297-305
  • Lade M, Mays H, Schmidt J, On the nanoparticle synthesis in microemulsions: detailed characterization of an applied reaction mixture. Colloid Surf A Physicochem 2000;163:3-15
  • Gash AE, Tilltson TM, Satcher JH, New sol-gel synthetic route to transition and maingroup metal oxide aerogels using inorganic salt precursors. J Non-cryst Solids 2001;285:22-8
  • Tang QL, Zhu Yj, Wu J, Calcium phosphate drug nanocarriers with ultrahigh and adjustable drug loading capacity: one step synthesis in situ drug loading and prolonged drug release. Nanomedicine 2011;7:428-34
  • Chakraborty M, Dasgupta S, Sengupta S, A facile synthetic strategy for Mg–Al layered double hydroxide material as nanocarrier for methotrexate. Ceram Int 2012;38:941-9
  • Liu TY, Chen SY, Liu DM, Liou SC. On the study of BSA-loaded calcium-deficient hydroxyapatite nano-carriers for controlled drug delivery. J Control Release 2005;107:112-21
  • Silverstei SC, Ralph MS, Zanvil AC. Endocytosis. Annu Rev Biochem 1977;46:669-722
  • Geiser M, Rothen-Rutishauser B, Kapp N, Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 2005;113:1555-60
  • Sahaya G, Alakhovaa DY, Kabanova AV. Endocytosis of nanomedicines. J Control Release 2010;145:182-95
  • Xu ZP, Zeng QH, Lu GQ, Yu AB. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci 2006;61:1027-40
  • Constantine PF, Prabhakar RB. Toxicity issues in the application of carbon nanotubes biological systems. Nanomedicine 2010;6:245-56
  • Donaldson K, Stone V, Tran CL. Nanotoxicology. Occup Environ Med 2004;61:727-8
  • Wibke B, Susanne B, Ulrike T, Internalisation of engineered nanoparticles into mammalian cells in vitro: influence of cell type and particle properties. J Nanopart Res 2011;13:293-310
  • Johnson AK, Zawadzka AM, Deobald LA, Novel method for immobilization of enzymes to magnetic nanoparticles. J Nanopart Res 2008;10(6):1009-25
  • Goyal AK, Khatri K, Mishra N, Development of self-assembled nanoceramic carrier construct(s) for vaccine delivery. J Biomater Appl 2009;24:65-84
  • Roy I, Ohulchanskyy T, Pudavar H, Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc 2003;125(7):860-7865
  • Chen Y, Chen H, Ma M, Double mesoporous silica shelled spherical/ellipsoidal nanostructures: synthesis and hydrophilic/hydrophobic anticancer drug delivery. J Mater Chem 2011;21:5290-8
  • Wei M, Xu Y, Zou Qi, Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin. Eur J Pharm Sci 2012;46:131-41
  • Zu Y, Zhang Y, Zhao X, Preparation and characterization of chitosan–polyvinyl alcohol blend hydrogel for the controlled release of nano- insulin. Int J Biol Macromol 2012;50(1):82-7
  • Saraf S. Process optimization for the production of nanoparticles for drug delivery applications. Expert Opin Drug Deliv 2009;6:187-96
  • Yun J, Yupin S, Xi Z, Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials 2012;33:1573-82
  • Su FY, Lin KJ, Sonaje K, Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. Biomaterials 2012;33:2801-11
  • Merwe Van der SM, Verhoef JC, Kotze AF, Junginger HE. N-Trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery- development and characterization of minitablet and granule formulations. Eur J Pharm Biopharm 2004;57:85-91
  • Niu M, Hovgaard L, Lua Y, Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose. Eur J Pharm Biopharm 2012;81(2):265-72
  • Giovino C, Ayensu I, Tetteh J, Boateng JS. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules. Int J Pharm 2012;428:143-51
  • Uchida T, Sakakibara S, Toida Y, Rectal delivery of insulin using a bioadhesive hydrogel preparation containing lauric acid as an enhancer in rats. Pharm Pharmacol Commun 1999;5(8):523-7
  • Amidi M, Romeijn G, Borchard G, Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release 2006;111:107-16
  • Longenecker JP, Moses AC, Flier JS, Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep. J Pharm Sci 1987;76(5):351-5
  • Higashi T, Hirayama F, Arima H, Uekama K. Polypseudorotaxanes of PEGylated insulin with cyclodextrins: application to sustained release system. Bioorg Med Chem Lett 2007;17(7):1871-4
  • Youn YS, Kwon MJ, Na DH, Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: optimization by PEG size selection. J Control Release 2008;125:68-75
  • Yan Z, Wang F, Ziyi W, LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor. J Control Release 2012;157:118-25
  • Al-Qadi S, Grenha A, Carrion DR, Microencapsulated chitosan nanoparticle for pulmonary protein delivery: in vivo evaluation of insulin loaded formulations. J Control Release 2012;157:383-90
  • Bachar M, Mandelbaum A, Portnaya I, Development and characterization of a novel drug nanocarrier for oral delivery based on self-assembled beta-casein micelle. J Control Release 2012;160:164-71
  • Wang P, Liu HJ, Mei XY, Preliminary study into the factors modulating beta-carotene micelle formation in dispersions using an in vitro digestion model. Food Hydrocoll 2012;26:427-33
  • Zeinali M, Jammalan M, Ardestani SK, Mosaveri N. Immunological and cytotoxicological characterization of tuberculin purified protein derivative (PPD) conjugated tosingle walled carbon nanotubes. Immunol Lett 2009;126:48-53
  • Liu C, Wang Q, Shen JW, On the spontaneous encapsulation of proteins in carbon nanotubes. Biomaterials 2009;30:2807-15
  • Prombutara P, Kulwatthanasal Y, Supaka N, Production of nisin-loaded solid lipid nano particle for sustained antimicrobial activity. Food Contr 2012;24:184-90
  • Hu FQ, Hong Y, Yuan H. Preparation and characterization of solid lipid nanoparticles containing peptide. Int J Pharm 2004;273:29-35
  • Cherian AK, Rana AC, Jain SK. Self-assembled carbohydrate-stabilized ceramic nanoparticles for the parenteral delivery of insulin. Drug Dev Ind Pharm 2000;26:459-63
  • Singh M, Singh D, Saraf S, Saraf S. Influence of selected formulation variables on the preparation of peptide loaded lipospheres. Trend Med Res 2011;6:101-15
  • Alles N, Soysa NS, Hussain MA, Polysaccharide nanogel delivery of a TNF-alpha and RANKL antagonist peptideallows systemic prevention of bone loss. Eur J Pharm Sci 2009;37:83-8
  • Gaertner HF, Cerini F, Kamath A, Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticles. Bioconjug Chem 2011;22(6):1103-14
  • Trindade RA, Kiyohara PK, Araujo PS, Bueno da Costa MH. PLGA microspheres containing bee venom proteins for preventive immunotherapy. Int J Pharm 2012;423:124-33
  • Singh M, Singh D, Saraf S, Saraf S. Formulation optimization of controlled delivery system for antihypertensive peptide using response surface methodology. Am J Drug Discov Deliv 2011;1(3):174-87
  • Singh D, Dixit VK, Saraf S, Saraf S. Formulation optimization of serratiopeptidase loaded PLGA microspheres using selected variables. PDA J Pharm Sci Technol 2009;63(2):103-12
  • Liu H, Webster TJ. Mechanical properties of dispersed ceramic nanoparticles in polymer composites for orthopedic applications. Int J Nanomed 2010;5:299-313
  • Paul W, Sharma C. Porous hydroxyapatite nanoparticles for intestinal delivery insulin. Trends Biom Artif Organs 2001;14(2):37-8
  • Wernike E, Montjovent MO, Liu Y, VEGF incorporated into calcium phosphate ceramic promotes vascularization and bone formation in vivo. Eur Cell Mater 2010;19:30-4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.